Expedited Reporting

December 11, 2018

Safety reporting to investigators (SUSARs): Mistakes you will never make again

All adverse drug reactions (ADRs) that are both serious and unexpected (Suspected Unexpected Serious Adverse Reactions, SUSARs) are subject to expedited reporting. Since the main objective of pharmacovigilance is the identification of information that may affect the safety of patients, once a potential risk is noted, it must be communicated […]
You’re Just Seconds Away From The Essential GCP Training & Advice JOIN TODAY